Tony Kim | Chief Financial Officer |
Peter Hoang | President and Chief Executive Officer |
Mythili Koneru | Senior Vice President-Clinical Development |
Jackson Harvey | Nomura/Instinet |
Ted Tenthoff | Piper Jaffray |
Matt Biegler | Oppenheimer & Company |
Tony Butler | Roth Capital |
Yun Zhong | Janney |
Greetings, and welcome to the Marker Therapeutics’ Third Quarter 2019 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to our host, Tony Kim, Chief Financial Officer.